loading page

Cardiorespiratory complications in pediatric oncology patients with COVID-19 infection
  • +1
  • Peter Schoettler,
  • Paul Sue,
  • Tamra Slone,
  • Andrew Koh
Peter Schoettler
The University of Texas Southwestern Medical Center Department of Pediatrics

Corresponding Author:[email protected]

Author Profile
Paul Sue
University of Texas Southwestern Department of Pediatrics
Author Profile
Tamra Slone
University of texas Southwestern Medical Center
Author Profile
Andrew Koh
UT Southwestern
Author Profile


The risk of the novel coronavirus disease 2019 (COVID-19) to pediatric oncology patients is unknown. Here, we report eight pediatric oncology patients receiving active cancer therapy that tested positive for COVID-19. Three developed severe cardiorespiratory symptoms (as defined by evidence of heart failure by echocardiogram and/or intubation secondary to respiratory failure), including one death as a result of COVID-19 infection. We identified prior anthracycline exposure and pre-COVID cardiac function as significantly associated with the development of severe cardiorespiratory complications. These data merit future and further investigation of risk factors for severe complications related to COVID-19 infections in pediatric oncology patients.